View original post here:
Skye Bioscience Appoints Kaitlyn Arsenault as Chief Financial Officer
Author Archives: Fredricko
Journey Medical Corporation Appoints Ernest De Paolantonio as Chief Financial Officer
Genovac Purchases Third Beacon® Optofluidic System and Expands its Capabilities into Cell Line Development
Albireo Recognizes PFIC Awareness Day 2021
Read the rest here:
Albireo Recognizes PFIC Awareness Day 2021
Scopus BioPharma to Present at the LD Micro Main Event
Continue reading here:
Scopus BioPharma to Present at the LD Micro Main Event
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
See the original post:
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
Read the original here:
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
Levitee Labs Publishes First Revenue Figures for August 2021
Continued here:
Levitee Labs Publishes First Revenue Figures for August 2021
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Originally posted here:
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
Read the original here:
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference
Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted…
Neuronetics Announces Commercial Agreement with Success TMS
Continued here:
Neuronetics Announces Commercial Agreement with Success TMS